Tag: Covid Vaccine

Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. The vaccine is one of India's two main vaccines against Covid pandemic under mass vaccination drive.

No serious adverse event was reported. 374 subjects reported either mild or moderate severity symptoms with 78.6 per cent getting resolved within one day.

"This announcement is an important first step in vaccinating the world and halting the pandemic. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant, Hotez said.

Union Health Secretary, Rajesh Bhushan categorically underlined that the government has not issued any directions on the requirement of the doctor's certificate to establish comorbidity at the vaccination centre.

The Hyderabad-based company, Biological E said these capacities will enable it to deliver 300 million doses as promised to the Government of India. Soon, the company plans to deliver more than one billion additional doses globally.

India Announces Booster Dose For Specific Categories

According to new guidelines issued by the Union health ministry on Monday, the vaccine option against COVID-19 for children in the age group of 15-18 years, who will be inoculated from January 3, would be Covaxin only

On the ongoing RDA strike which has hit all the medical services in the national capital, the IMA said that the issue of expediting PG counselling is the need of the hour to increase manpower ahead of the looming third wave threat.

Israel and Germany have also announced the roll out of a booster shot to tackle, while the UK may soon follow with recommendations from the Joint Committee on Vaccination and Immunisation (JCVI).

The decline in effectiveness begins to first appear at around three months, when the risk of hospitalisation and death is double that of two weeks after the second dose.

While the 100 microgram booster dose was "generally safe and well tolerated", however, there "was a trend toward slightly more frequent adverse reactions" following it compared to the authorised dose.

Currently, the WHO recommends administering a third dose of any WHO-approved vaccine to those who are immunocompromised. It has also recommended a booster for recipients of the Chinese vaccines who are older than 60, where supplies allow.

Globally, the supply of vaccines has outmatched the demand and to keep up with the momentum, countries need to join and form some agreement in order to prepare standard rules for clinical trials and manufacturing of the vaccines.

While current Covid-19 vaccines use genes taken from the virus spike protein to encode antigens, which causes the immune system to produce antibodies, the new vaccine uses predictive methods to mimic the wider family of coronavirus antigens that researchers hope will give more protection.

According to the findings of the IANS-CVoter Covid Vaccine Tracker, of the 90 crore adult population of the country, more than 81 crore people have got their Dose 1 of the Covid-19 vaccine.